| Hans-Günter Meyer-Thompson | Hepatitiden
Hepatitis B: Vemlidy - tenofovir alafenamide (EMA, Summary of opinion (initial authorisation))
EMA/704543/2016
Committee for Medicinal Products for Human Use (CHMP)
Summary of opinion (initial authorisation)
10 November 2016